India ·
API Holdings sells another 9.9% of Thyrocare on the open market, clearing its last ₹1,050cr of debt
PharmEasy parent API Holdings' Docon Technologies sold 1.58 crore Thyrocare shares (9.90% of the diagnostics chain) through open-market trades at a stock price of ₹653 — a roughly 51% premium to its bonus-adjusted 2021 entry price of ₹433 — using the proceeds to repay its last ₹1,050 crore of debt and free the rest of its now-51.02% holding from pledge.
Source: Inc42 ↗
Frequently asked questions
Is this an original report, or a copy of the source article?
This is original commentary and context written for this site, citing Inc42 as the source. Read the full original reporting at the source link below.
How current is this information?
This item reflects reporting as of 17 August 2026. Secondary-market situations like this one can change quickly — check the source link for the latest developments.